Subjective assessment of brexpiprazole in patients with schizophrenia: a prospective observational study.

Yokoi, Rina; Hatano, Masakazu; Kamei, Hiroyuki; Morita, Aoi; Hanya, Manako; Iwata, Nakao; Yamada, Shigeki

Yokoi, Rina; Hatano, Masakazu; Kamei, Hiroyuki; Morita, Aoi; Hanya, Manako; Iwata, Nakao; Yamada, Shigeki.

Afiliação

Yokoi R; Department of Pharmacotherapeutics and Informatics, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Hatano M; Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan.
Kamei H; Department of Pharmacotherapeutics and Informatics, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Morita A; Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan.
Hanya M; Department of Psychiatry, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Iwata N; Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan.
Yamada S; Department of Psychiatry, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.

Fujita Med J ; 9(3): 231-235, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37554938

Palavras-chave

Antipsychotic agents; Brexpiprazole; Drug attitude; Schizophrenia; Subjective well-being

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Fujita Med J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google